{"transactions":[{"id":711139,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T21:00:13.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.69,"expiration_date":"2036-07-08","underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-082761","document":"tm2620238-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465926082761/tm2620238-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-07-08"}},{"id":712562,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:00:38.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.68,"expiration_date":"2036-07-08","underlying":"Common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-082009","document":"tm2620095-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465926082009/tm2620095-1_4seq1.xml","form_type":"4"}},{"id":1263621,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:05:52.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-014752","document":"tm256830-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465925014752/tm256830-6_4seq1.xml","form_type":"4"}},{"id":1475092,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:01:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.58,"expiration_date":"2033-12-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-072883","document":"tm2417520-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465924072883/tm2417520-5_4seq1.xml","form_type":"4"}},{"id":1842640,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-28T22:25:32.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":47885,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-075939","document":"tm2320030-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465923075939/tm2320030-3_4seq1.xml","form_type":"4"}},{"id":2199004,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-08-01T22:01:20.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022."}],"balance_after":7800,"derivative":{"exercise_price":4.1,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001104659-22-084837","document":"tm2222253-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465922084837/tm2222253-3_4seq1.xml","form_type":"4"}},{"id":2644444,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T20:03:32.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on the first anniversary of the date of grant."}],"balance_after":78000,"derivative":{"exercise_price":1.19,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-21-088839","document":"tm2120855-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465921088839/tm2120855-4_4seq1.xml","form_type":"4"}},{"id":3099714,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:24:03.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076875","document":"tm2023456d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000110465920076875/tm2023456d6_4.xml","form_type":"4"}},{"id":3489479,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-14T20:32:00.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest on the one year anniversary of the date of grant."}],"balance_after":6500,"derivative":{"exercise_price":2.15,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001144204-19-031008","document":"tv523609_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000114420419031008/tv523609_4.xml","form_type":"4"}},{"id":3790615,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-10-15T23:50:43.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was divided into a definitive grant of 6,150 shares, which vest in equal monthly installments over a seven month period from the grant date, and a contingent grant of 6,850 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest immediately upon such stockholder approval."}],"balance_after":13000,"derivative":{"exercise_price":2.61,"expiration_date":"2028-10-12","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001144204-18-053881","document":"tv504846_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000114420418053881/tv504846_form4.xml","form_type":"4"}},{"id":4276489,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-20T16:32:47.000Z","date":"2017-06-16","kind":"exercise","acquired":false,"shares":1500,"price":3.8,"value":5700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, the vesting date of unvested stock options accelerated to vest and become exercisable as of the closing of the merger."}],"balance_after":0,"derivative":{"exercise_price":3.8,"exercise_date":"2017-06-16","expiration_date":"2017-06-16","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001123292-17-001159","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001159/edgar.xml","form_type":"4"}},{"id":4276488,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:32:47.000Z","date":"2017-06-16","kind":"disposition_to_issuer","acquired":false,"shares":1207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated January 24, 2017, among the Issuer, Intrexon Corporation (\"Intrexon\") and Intrexon GV Holding, Inc. (the \"Merger Agreement\") in exchange for (i) 358 shares of Intrexon common stock having a market value of $8,170 as of the close of trading on the date immediately prior to the effective date of the merger, and cash in lieu of fractional shares of Intrexon common stock, plus (ii) one contingent payment right (the \"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"[footnote 2 continued] Each contingent payment right entitles the holder thereof to an amount equal to half of certain payments actually received by the registrant or its successor or any of their affiliates from or on behalf of Novartis Institutes for BioMedical Research, Inc. (\"Novartis\") under the Research Collaboration and License Agreement, dated January 13, 2010, as amended, between the registrant and Novartis, on account of milestone payments or royalties due in relation to the period ending June 16, 2019, divided by the number of shares of the regisrant's common stock having rights to the Merger Consideration, subject to any withholding of taxes required by applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-17-001159","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001159/edgar.xml","form_type":"4"}},{"id":4276487,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:32:47.000Z","date":"2016-06-16","kind":"tax_withholding","acquired":false,"shares":793,"price":7.19,"value":5701.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Withholding of Common Stock to pay exercise price and to satisfy tax withholding obligations."}],"balance_after":1207,"source":{"system":"sec-edgar","filing":"0001123292-17-001159","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001159/edgar.xml","form_type":"4"}},{"id":4276486,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:32:47.000Z","date":"2017-06-16","kind":"exercise","acquired":true,"shares":1500,"price":3.8,"value":5700.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001123292-17-001159","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001159/edgar.xml","form_type":"4"}},{"id":4298042,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-01T22:02:02.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal annual increments over a period of three years from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":1.74,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-17-030680","document":"v468269_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441500/000114420417030680/v468269_4.xml","form_type":"4"}},{"id":4506165,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-01-04T18:21:19.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2017, and options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2018."}],"balance_after":81000,"derivative":{"exercise_price":0.17,"expiration_date":"2022-01-03","underlying":"common stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001493152-17-000142","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315217000142/form4.xml","form_type":"4"}},{"id":4551917,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2016-11-17T17:30:43.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":0.1,"exercise_date":"2016-11-15","expiration_date":"2021-11-15","underlying":"Common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-16-015243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315216015243/form4.xml","form_type":"4"}},{"id":4575767,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":30981,"kind":"person","name":"Loren Stefan","position":1,"cik":"0001441500","reported_name":"Loren Stefan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2016-10-24T16:44:20.000Z","date":"2016-10-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":0.38,"exercise_date":"2017-10-20","expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-16-083399","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/934473/000114036116083399/doc1.xml","form_type":"4"}}]}